Learn more

HTG MOLECULAR DIAGNOSTICS INC

Overview
  • Total Patents
    56
  • GoodIP Patent Rank
    68,197
  • Filing trend
    ⇩ 100.0%
About

HTG MOLECULAR DIAGNOSTICS INC has a total of 56 patent applications. It decreased the IP activity by 100.0%. Its first patent ever was published in 2008. It filed its patents most often in Australia, EPO (European Patent Office) and United States. Its main competitors in its focus markets biotechnology, pharmaceuticals and computer technology are ZYTOVISION GMBH, BANKAITIS-DAVIS DANUTE M and QIAGEN MANSFIELD INC.

Patent filings per year

Chart showing HTG MOLECULAR DIAGNOSTICS INCs patent filings per year from 1900 to 2020

Top inventors

# Name Total Patents
#1 Seligmann Bruce 26
#2 Rounseville Matt 20
#3 Thompson Debrah 17
#4 Maddula Krishna 13
#5 Botros Ihab 12
#6 Vasicek Tom 11
#7 Rounseville Matthew 8
#8 Wang Hui 8
#9 Luecke John W 7
#10 Gordon Debra A 7

Latest patents

Publication Filing date Title
WO2020142153A1 Methods of detecting dna and rna in the same sample
AU2017218112A1 Method of direct target sequencing using nuclease protection
WO2017059108A1 Methods for subtyping diffuse b-cell lymphoma (dlbcl)
AU2015203545A1 Quantitative nuclease protection assay (qnpa) and sequencing (qnps) improvements
WO2015069787A1 Methods for detecting nucleic acids
US2016019337A1 Subtyping lung cancers
AU2013282319A1 Nuclease protection methods for detection of nucleotide variants
AU2013277971A1 Molecular malignancy in melanocytic lesions
US2013288915A1 Compositions and methods for alk molecular testing
AU2012316129A1 Methods of co-detecting mRNA and small non-coding RNA
CA2834976A1 Quantitative nuclease protection assay (qnpa) and sequencing (qnps) improvements
EP2726628A1 Methods of detecting gene fusions
EP2496715A1 Quantitative nuclease protection sequencing (qnps)